Log in to save to my catalogue

Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infant...

Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infant...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e67ddb93f0df4fe1a7008a5e8aa42403

Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders

About this item

Full title

Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2017-06, Vol.12 (1), p.113-113, Article 113

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Neuronal Ceroid Lipofuscinosis (NCL), also known as Batten disease, is a group of genetically distinct lysosomal disorders that mainly affect the central nervous system, resulting in progressive motor and cognitive decline primarily in children. Multiple distinct genes involved in the metabolism of lipids have been identified to date with various m...

Alternative Titles

Full title

Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e67ddb93f0df4fe1a7008a5e8aa42403

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e67ddb93f0df4fe1a7008a5e8aa42403

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-017-0663-8

How to access this item